Morning Light Therapy for Postpartum Depression

Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression

Recruiting N/A Interventional Study
Postpartum Depression (PPD)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Other
Participants needed
30 (estimated)
Sponsor
University of Michigan · Other
Who this trial is looking for

This trial is looking for women who are up to 6 months postpartum and are experiencing symptoms of postpartum depression. Participants will try a morning light therapy device to see how well it works and how easy it is to use.

Are You a Good Fit for This Trial?
Rules you out EpilepsySeizures

You may be able to join if

  • I am 6 months postpartum or less
  • I have an EPDS score greater than 10

You may not be able to join if

  • I have a current or past-year substance use disorder
  • I have a lifetime history of bipolar disorder or psychotic disorder
  • I have active suicidal intent
  • I have retinal pathology or a history of eye surgery
  • I am currently using photosensitizing medications
  • I have untreated sleep-disordered breathing, restless legs syndrome, or narcolepsy
  • I started psychotherapy or changed the dose of psychotropic medications in the past month
  • I have medical conditions that are not safe for bright light therapy

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. ≤ 6 months postpartum 2. EPDS score \>10 Exclusion Criteria: 1. Current or past-year substance use disorder 2. Lifetime history of bipolar disorder or psychotic disorder 3. Active suicidal intent 4. Retinal pathology or history of eye surgery 5. Current use of photosensitiz…
Contacts

Kelley DuBuc

734-764-1904

dubuck@med.umich.edu

CONTACT